Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis
- PMID: 25962362
- DOI: 10.1007/s00391-015-0892-1
Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis
Abstract
Background: Genetic mutations in the paraoxonase 1 (PON1) encoding gene have been considered to affect mortality and of these the functional promoter region polymorphisms Q192R and L55M are among the most widely studied.
Objective: The aim of this study was to determine whether the Q192R and L55M polymorphisms of PON1 can increase susceptibility to longevity. A meta-analysis was performed to obtain a comprehensive estimation of the association between Q192R and L55M and longevity in long-lived individuals (LLIs) aged 80 years or more.
Material and methods: A search was carried out in the PubMed database (from January 2001 to May 2014) to obtain data on the role of PON1 polymorphisms in longevity and a pooled odds ratio (OR) with a 95% confidence interval (CI) was used to assess the associations.
Results: The meta-analysis was based on 9 studies of PON1 Q192R and 5 studies of PON1 L55M that covered a total of 5086 LLIs and 4494 controls. Overall, significantly increased risks were not observed for either Q192R or L55M. The results of the statistical calculations were as follows: R vs. Q (additive model): OR = 1.080, 95% CI = 0.989-1.179, p = 0.088 and RR + RQ vs. QQ (dominant model): OR = 1.099, 95% CI = 0.975-1.240, p = 0.124; M vs. L (additive model): OR = 0.946, 95% CI = 0.862-1.039, p = 0.245 and MM + ML vs. LL (dominant model): OR = 0.951, 95% CI = 0.836-1.081, p = 0.442 for Q192R and L55M, respectively. The results did not change with an age cut-off among the LLIs of ≥ 93 years.
Conclusion: No evidence that the Q192R and L55M polymorphisms of PON1 impacted on the probability of reaching extreme ages was found although this cannot be completely ruled out; however, the possibility of population-specific effects due to the influence of and interaction between different genes or environmental factors could not be ruled out.
Keywords: Aged, 80 and over; Aging genetics; Alleles; Genotype; Humans.
Similar articles
-
Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: a meta-analysis.Neurosci Lett. 2012 Aug 15;523(2):174-9. doi: 10.1016/j.neulet.2012.06.071. Epub 2012 Jul 7. Neurosci Lett. 2012. PMID: 22776645
-
Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis.Neurol Sci. 2015 Jan;36(1):11-20. doi: 10.1007/s10072-014-1979-y. Epub 2014 Oct 10. Neurol Sci. 2015. PMID: 25301263 Review.
-
The Association between PON1 (Q192R and L55M) Gene Polymorphisms and Risk of Cancer: A Meta-Analysis Based on 43 Studies.Biomed Res Int. 2019 Jul 28;2019:5897505. doi: 10.1155/2019/5897505. eCollection 2019. Biomed Res Int. 2019. PMID: 31467900 Free PMC article. Review.
-
Association of paraoxonase 1 (PON1) L55M and PON1 Q192R gene polymorphisms and risk of psoriasis.G Ital Dermatol Venereol. 2019 Jun;154(3):321-326. doi: 10.23736/S0392-0488.17.05514-6. Epub 2017 Apr 11. G Ital Dermatol Venereol. 2019. PMID: 28399619
-
The Paraoxonase 1 Gene c.-108C>T SNP in the Promoter Is Associated with Risk for Glioma in Mexican Patients, but Not the p.L55M or p.Q192R Polymorphisms in the Coding Region.Genet Test Mol Biomarkers. 2015 Sep;19(9):494-9. doi: 10.1089/gtmb.2014.0322. Epub 2015 Jul 8. Genet Test Mol Biomarkers. 2015. PMID: 26154629
Cited by
-
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.Vasc Health Risk Manag. 2018 Jun 18;14:137-143. doi: 10.2147/VHRM.S165173. eCollection 2018. Vasc Health Risk Manag. 2018. PMID: 29950852 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous